<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02011568</url>
  </required_header>
  <id_info>
    <org_study_id>2013106-01</org_study_id>
    <nct_id>NCT02011568</nct_id>
  </id_info>
  <brief_title>Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients</brief_title>
  <acronym>CAPITALCHILL</acronym>
  <official_title>Therapeutic Hypothermia Following Out-of-Hospital Cardiac Arrest - A Randomized Trial Comparing Mild and Moderate Therapeutic Hypothermia (CAPITAL CHILL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Heart Institute Research Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Heart Institute Research Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is currently a single-center, randomized, double-blind investigator initiated&#xD;
      prospective clinical trial initiated at the University of Ottawa Heart Institute (UOHI). The&#xD;
      plan is to expand the trial shortly as a multi-center project. The patients for this study&#xD;
      will be recruited amongst comatose survivors of out-of-hospital cardiac arrest (OHCA). The&#xD;
      aim of this study is to determine whether neurologic outcomes at six months are improved with&#xD;
      moderate (31 degrees Celsius) versus mild (34 degrees Celsius) therapeutic hypothermia (TH)&#xD;
      following return of spontaneous circulation (ROSC) in patients suffering OHCA, with ROSC&#xD;
      defined as the resumption of sustained perfusing cardiac activity.&#xD;
&#xD;
      The primary outcome will be the proportion of patients experiencing death or a poor&#xD;
      neurologic outcome at six months after out of hospital cardiac arrest.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">March 2020</completion_date>
  <primary_completion_date type="Actual">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with death or poor neurologic outcome at 6 months</measure>
    <time_frame>Six months</time_frame>
    <description>The primary outcome of the study will be death or poor neurologic outcome at six months. Neurologic outcome will be assessed by a specialist in rehabilitation medicine using the Disability Ratings Scale (DRS. Patients will be judged to have had a poor neurologic outcome if the score on the DRS scale is &gt;5.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of mortality</measure>
    <time_frame>30 days and 6 months</time_frame>
    <description>All cause mortality will be recorded. Mortality will be adjudicated as cardiac versus non-cardiac.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with stroke</measure>
    <time_frame>30 days and 6 months</time_frame>
    <description>Stroke will be classified as hemorrhagic versus non-hemorrhagic.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with bleeding</measure>
    <time_frame>During index hospitalization</time_frame>
    <description>Bleeding will be assessed using the TIMI definition and will be scored as major or minor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the unit</measure>
    <time_frame>Admission to unit to discharge from unit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the hospital</measure>
    <time_frame>Admission to hospital to discharge from hospital.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with cardiogenic shock</measure>
    <time_frame>During index hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with repeat circulatory arrest requiring cardiopulmonary resuscitation (CPR)</measure>
    <time_frame>Six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with seizures</measure>
    <time_frame>During index hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with renal failure requiring renal replacement therapy</measure>
    <time_frame>During index hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with ventilator associated pneumonia</measure>
    <time_frame>During index hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with stent thrombosis</measure>
    <time_frame>Six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants discharged home</measure>
    <time_frame>Six months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Moderate hypothermia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Therapeutic hypothermia at 31 degrees celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild Hypothermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapeutic Hypothermia at 34 degrees Celsius</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapeutic Hypothermia</intervention_name>
    <arm_group_label>Mild Hypothermia</arm_group_label>
    <arm_group_label>Moderate hypothermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Out of hospital cardiac arrest patient&#xD;
&#xD;
          2. Return of spontaneous circulation&#xD;
&#xD;
          3. Glasgow Coma Score equal or lesser than 8.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients residing in a Nursing Home or patients unable to reside independently,&#xD;
&#xD;
          2. Intracranial bleed responsible for the cardiac arrest,&#xD;
&#xD;
          3. Severe coagulopathy with clinical evidence of major bleeding,&#xD;
&#xD;
          4. Coma that is not attributable to cardiac arrest,&#xD;
&#xD;
          5. Pregnancy,&#xD;
&#xD;
          6. Life expectancy of &lt; one year due to any cause unrelated to the cardiac arrest,&#xD;
&#xD;
          7. Known coagulation disorder (i.e. INR &gt;2.0, platelets &lt;100,000 / mm3),&#xD;
&#xD;
          8. Participation in a study with another investigational device or drug &lt; four weeks,&#xD;
&#xD;
          9. The Endovascular cooling (ZOLL) device is not available.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel R Le May, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>k1y 4w7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>November 8, 2013</study_first_submitted>
  <study_first_submitted_qc>December 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2013</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ottawa Heart Institute Research Corporation</investigator_affiliation>
    <investigator_full_name>Michel Le May</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <keyword>Therapeutic Hypothermia</keyword>
  <keyword>Out of hospital cardiac arrest</keyword>
  <keyword>Mild hypothermia</keyword>
  <keyword>Moderate hypothermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

